Cytosorbents Corporation
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $4.4M | $4.8M | $6.2M | $7.5M | $10.2M | $11.6M | $3.3M | $5.7M |
| Accounts Receivable | $6.8M | $7.2M | $7.6M | $7.4M | $7.7M | $7.7M | $7.3M | $6.6M |
| Inventory | $3.7M | $4.5M | $5.3M | $4.0M | $3.7M | $3.0M | $2.7M | $3.2M |
| Total Current Assets | $15.7M | $17.8M | $20.6M | $21.3M | $23.0M | $25.4M | $21.6M | $16.6M |
| Property, Plant & Equipment | $7.2M | $7.5M | $7.8M | $8.2M | $8.5M | $8.7M | $9.0M | $9.3M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $2.9M | $3.0M | $3.2M | $3.6M | $3.7M | $3.7M | $3.7M | — |
| Total Assets | $38.0M | $40.6M | $44.2M | $45.8M | $48.0M | $50.8M | $47.4M | $47.8M |
| Liabilities | ||||||||
| Accounts Payable | $2.0M | $3.1M | $2.9M | $3.0M | $3.4M | $3.3M | $3.3M | $2.3M |
| Total Current Liabilities | $24.0M | $16.3M | $9.7M | $10.1M | $9.8M | $9.7M | $9.8M | $8.3M |
| Long-Term Debt | $3.1M | $10.3M | $16.7M | $14.6M | $14.4M | $14.2M | $14.0M | $13.8M |
| Total Liabilities | $38.7M | $38.4M | $38.3M | $36.7M | $36.4M | $36.2M | $36.3M | $34.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-321.8M | $-317.3M | $-312.2M | $-306.7M | $-303.5M | $-305.5M | $-304.0M | $-296.4M |
| Total Stockholders' Equity | $-751.0K | $2.2M | $5.9M | $9.0M | $11.6M | $14.5M | $11.1M | $13.4M |